PROTIVA BIOTHERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 37218
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2871
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 27140
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 7131
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
 
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
 
 
B82Y SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE  OR TREATMENT OF NANO-STRUCTURES251
 
 
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,397 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSNov 20, 17Mar 15, 18[A61K, C12N]
2017/0258,719 LIPOSOMAL APPARATUS AND MANUFACTURING METHODSOct 20, 16Sep 14, 17[A61K]
2017/0151,333 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFSep 09, 16Jun 01, 17[A61K, C07D, C07C]
2016/0151,284 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAJul 22, 14Jun 02, 16[A61K]
2011/0262,527 CATIONIC LIPIDS AND METHODS OF USEJun 08, 10Oct 27, 11[A61K, C12N, C07C, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9878042 Lipid formulations for delivery of therapeutic agents to solid tumorsJan 27, 15Jan 30, 18[C07H, A61K, C12N]
9765333 Compositions and methods for silencing marburg virus gene expressionAug 21, 15Sep 19, 17[A61K, C12N]
9518272 Non-liposomal systems for nucleic acid deliveryMay 12, 16Dec 13, 16[C07H, A61K, C12N]
9504651 Lipid compositions for nucleic acid deliveryJun 13, 14Nov 29, 16[A61K, B01J]
9492386 Liposomal apparatus and manufacturing methodsNov 21, 12Nov 15, 16[A61K]
9428751 Compositions and methods for silencing apolipoprotein C-III expressionApr 01, 15Aug 30, 16[A61K, C07H, B82Y, C12N]
9404127 Non-liposomal systems for nucleic acid deliveryMar 09, 15Aug 02, 16[C07H, A61K, C12N]
9364435 Lipid formulations for nucleic acid deliveryAug 18, 14Jun 14, 16[A61K, C07H, C12N, C07J]
9352042 Trialkyl cationic lipids and methods of use thereofFeb 22, 13May 31, 16[A61K, C12N, C07C]
9222086 Compositions and methods for silencing genes expressed in cancerSep 23, 10Dec 29, 15[A61K, C07H, C12Q, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0042,814 NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERYAbandonedMay 25, 16Feb 16, 17[A61K, C12N]
2016/0256,567 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2016/0256,568 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2014/0288,146 NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedApr 25, 13Sep 25, 14[A61K, C07C]
2013/0178,511 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNAAbandonedJul 17, 12Jul 11, 13[C12N]
2013/0122,104 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSAbandonedAug 03, 12May 16, 13[A61K]
2013/0123,338 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedMay 12, 11May 16, 13[A61K, C07D, C07C]
2013/0022,649 SNALP FORMULATIONS CONTAINING ANTIOXIDANTSAbandonedDec 01, 10Jan 24, 13[A61K, B82Y]
2012/0058,188 LIPID ENCAPSULATED INTERFERING RNAAbandonedJun 24, 11Mar 08, 12[A61K, B82Y, C12N, A61P]
2011/0313,017 SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATESAbandonedJan 13, 11Dec 22, 11[A61K, C12N]
2011/0224,418 MODIFIED sIRNA MOLECULES AND USES THEREOFAbandonedFeb 14, 11Sep 15, 11[C07H]
2011/0189,300 siRNA SILENCING OF APOLIPOPROTEIN BAbandonedMay 20, 10Aug 04, 11[A61K, A61P]
2011/0177,131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONAbandonedSep 09, 10Jul 21, 11[A61K, C07H, B82Y, A61P]
2011/0071,208 LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNAAbandonedJun 04, 10Mar 24, 11[A61K, C12N, A61P]
2008/0171,716 NUCLEIC ACID MODULATION OF TOLL-LIKE RECEPTOR-MEDIATED IMMUNE STIMULATIONAbandonedAug 15, 07Jul 17, 08[A61K, C07H, A61P]
2007/0218,122 siRNA silencing of influenza virus gene expressionAbandonedNov 17, 06Sep 20, 07[A61K, C07H]
2007/0054,873 Glucocorticoid modulation of nucleic acid-mediated immune stimulationAbandonedAug 28, 06Mar 08, 07[A61K]
2006/0160,790 Thioureas as factor Xa inhibitorsAbandonedDec 07, 05Jul 20, 06[A61K, C07D]
2006/0134,189 siRNA silencing of apolipoprotein BAbandonedNov 17, 05Jun 22, 06[A61K, C07H, C12N]
2006/0051,405 Compositions for the delivery of therapeutic agents and uses thereofAbandonedJul 19, 05Mar 09, 06[A61K, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.